Evidence map›Paper›PMID 19564341›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2009

Regulation of dendritic cells and macrophages by an anti-apoptotic cell natural antibody that suppresses TLR responses and inhibits inflammatory arthritis.

Yifang Chen, Sahil Khanna, Carl S Goodyear, Yong Beom Park, Eyal Raz, Steffen Thiel, Caroline Grönwall, Jaya Vas, David L Boyle, Maripat Corr and 2 more

Open access · bronzeAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 94 papers.

0numbers the graph read from it
0cells of the map it votes in
94citing papers in PubMed
3.5field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

94 citing papers in PubMed, 158 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Review
  4. Review
  5. Article
  6. Oxidized phospholipids in cardiovascular disease.Nature reviews. Cardiology · 2024
    Review
  7. Article
  8. Review
  9. Article
  10. Review
  11. Review
  12. The OSE complotype and its clinical potential.Frontiers in immunology · 2022
    Review
  13. Review
  14. Article
  15. Observational
  16. CD5-Positive B Lymphocytes after Kidney Transplantation.Diagnostics (Basel, Switzerland) · 2021
    Article
  17. 14-3-3ζ: A suppressor of inflammatory arthritis.Proceedings of the National Academy of Sciences of the United States of America · 2021
    Article
  18. A Single Human VCell reports · 2020
    Article
  19. Observational
  20. Article

34 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 3 countries.

Yifang ChenLaboratory of B Cell Immunobiology, University of California, San Diego, La Jolla, CA 92093, USA.
Sahil Khanna
Carl S Goodyear
Yong Beom Park
Eyal Raz
Steffen Thiel
Caroline Grönwall
Jaya Vas
David L Boyle
Maripat Corr
Dwight H Kono
Gregg J Silverman
University of California San Diego · USAarhus University · DKScripps Research Institute · US

Funding

RHEUMATIC DISEASES CORE CENTERP30AR047360 · NIAMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI SILVERMAN, GREGG JOSHUA · 2001 to 2006
$3.4M
B CELL SUPERANTIGENS AND IMMUNE REGULATIONR01AI040305 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI SILVERMAN, GREGG JOSHUA · 1998 to 2008
$2.4M
Cell Death and Antibody-Mediated Protection from AutoimmunityR01AI068063 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI SILVERMAN, GREGG JOSHUA · 2006 to 2010
$2.1M
Lupus and the inhibitory dual receptor hypothesisR01AI090118 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI SILVERMAN, GREGG JOSHUA · 2010 to 2014
$2.0M
Mechanisms to Induce Protective Natural AutoimmunityR21AR050659 · NIAMS · UNIVERSITY OF CALIFORNIA SAN DIEGO · PI SILVERMAN, GREGG JOSHUA · 2003 to 2004
$152k
ENGINEERED B-CELL SUPERANTIGENS AND IMMUNE TOLERANCER03AI046637 · NIAID · UNIVERSITY OF CALIFORNIA SAN DIEGO · PI SILVERMAN, GREGG JOSHUA · 1999 to 2001
$152k
NIAID NIH HHS AI40305NIAID NIH HHS AI46637NIAID NIH HHS R01 AI040305NIAID NIH HHS R01 AI068063NIAID NIH HHS R01 AI090118NIAMS NIH HHS AR47360NIAMS NIH HHS AR50659NIAMS NIH HHS P30 AR047360NIAMS NIH HHS R21 AR050659
6 · The paper itself

Abstract

Although natural Abs (NAbs) are present from birth, little is known about what drives their selection and whether they have housekeeping functions. The prototypic T15-NAb, first identified because of its protective role in infection, is representative of a special type of NAb response that specifically recognizes and forms complexes with apoptotic cells and which promotes cell-corpse engulfment by phagocytes. We now show that this T15-NAb IgM-mediated clearance process is dependent on the recruitment of C1q and mannose-binding lectin, which have known immune modulatory activities that also provide "eat me" signals for enhancing phagocytosis. Further investigation revealed that the addition of T15-NAb significantly suppressed in vitro LPS-induced TNF-alpha and IL-6 secretion by the macrophage-like cell line, RAW264.7, as well as TLR3-, TLR4-, TLR7-, and TLR9-induced maturation and secretion of a range of proinflammatory cytokines and chemokines by bone marrow-derived conventional dendritic cells. Significantly, high doses of this B-1 cell produced NAb also suppressed in vivo TLR-induced proinflammatory responses. Although infusions of apoptotic cells also suppressed such in vivo inflammatory responses and this effect was associated with the induction of high levels of IgM antiapoptotic cell Abs, apoptotic cell treatment was not effective at suppressing such TLR responses in B cell-deficient mice. Moreover, infusions of T15-NAb also efficiently inhibited both collagen-induced arthritis and anti-collagen II Ab-mediated arthritis. These studies identify and characterize a previously unknown regulatory circuit by which a NAb product of innate-like B cells aids homeostasis by control of fundamental inflammatory pathways.

Indexed as

AnimalsAntibodiesApoptosisArthritis, ExperimentalB-LymphocytesCell LineComplement C1qDendritic CellsHomeostasisImmunity, InnateImmunoglobulin MInflammationMacrophagesMaleMannose-Binding LectinMiceAntibodiesComplement C1qImmunoglobulin MMannose-Binding LectinToll-Like Receptors

Identifiers

PMID19564341
PMCPMC2713016
OpenAlexW1554784279

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.